Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Hospital Medicine (London, England : 1998)|July 20, 2005
Bisphosphonates' use in metastatic bone diseaseR A Hubner, S J Houston
British Journal of Cancer|December 18, 2008
Folate and colorectal cancer preventionR A Hubner, R S Houlston
Annals of the Royal College of Surgeons of England|May 23, 2012
Prolonged survival after surgical management of metastases in malignant melanoma: three case reportsS R Whitaker, S J Houston
The Nursing Clinics of North America|September 1, 1992
Psychosocial implications of lung cancerS J Houston, J A Kendall
Clinical Orthopaedics and Related Research|March 1, 1995
The systemic treatment of bone metastasesS J Houston, R D Rubens
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2014
Second-line chemotherapy in advanced biliary cancer: a systematic reviewA Lamarca, R A Hubner, W David Ryder, et al.
Journal of Hypertension|June 8, 2001
In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilatR A Hubner, E Kubota, D J Casley, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 4, 2018
Urgent need for consensus: international survey of clinical practice exploring use of platinum-etoposide chemotherapy for advanced extra-pulmonary high grade neuroendocrine carcinoma (EP-G3-NEC)A Lamarca, M Frizziero, J Barriuso, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 20, 2016
Identification of clinical biomarkers for patients with advanced hepatocellular carcinoma receiving sorafenibA Lamarca, O Abdel-Rahman, I Salu, et al.
Lung Cancer (Amsterdam, Netherlands)|February 22, 2011
Influence of co-morbidity on renal function assessment by Cockcroft-Gault calculation in lung cancer and mesothelioma patients receiving platinum-based chemotherapyR A Hubner, R Goldstein, S Mitchell, et al.
Pageof 3